What researchers published on Follicular lymphoma
370 papers, newest first.
Showing 140 of 370
Et tu, CD70? When friend turns foe for follicular lymphoma.Blood
Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis.Cancer medicine
Beyond PET/CT: the evolving role of circulating tumor DNA in follicular lymphoma.Frontiers in immunology
Beyond the plateau: defining cure and charting the next decade in follicular lymphoma: redefining cure in follicular lymphoma.Medical oncology (Northwood, London, England)
Review[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewLow tumor burden follicular lymphoma: The state of the art.HemaSphere
Prognostic value of cell differentiation-related genes in follicular lymphoma based on integrated single-cell and bulk RNA sequencing.Neoplasma
Case reportPersistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma.ASM case reports
Case reportLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
Follicular Lymphoma: 2027 Annual Update.American journal of hematology
Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study.Targeted oncology
Baseline maximum standardised uptake value does not predict outcomes in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy.British journal of haematology
Case report[Composite follicular lymphoma and mantle cell lymphoma: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology
Assessment of BCL-2 expression in bone marrow by flow cytometry to aid in the diagnosis and differential diagnosis in patients with follicular lymphoma.Cytometry. Part B, Clinical cytometry
Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL.Blood advances
Review[Treatment strategies and future perspectives in follicular lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem).Pharmaceuticals (Basel, Switzerland)
Navigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma.Cancers
Clinical Characteristics, Progression of Disease Within 24 Months (POD24), and Real-World Outcomes of Follicular Lymphoma in Saudi Arabia: A Two-Centre Retrospective Analysis.Cancers
Adjusted Indirect Comparison Between Epcoritamab-R2 and Tafasitamab-R2 in Relapse/Refractory Follicular Lymphoma.Hematological oncology
CAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.British journal of haematology
Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.HemaSphere
Capsule retention revealing systemic follicular lymphoma with small-bowel involvement.Gastroenterologia y hepatologia
Real-world outcomes of mosunetuzumab use in relapsed/refractory indolent lymphomas: a CUBIC consortium analysis.Blood neoplasia
EZH2 mutation status predicts inferior outcomes after bendamustine-based immunochemotherapy in frontline follicular lymphoma: A GELTAMO multicenter validation study.HemaSphere
Intrafollicular PAI-1 Expression Is Associated with Absence of Histological Transformation During Long-Term Follow-Up in Follicular Lymphoma.International journal of molecular sciences
Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.International journal of molecular sciences
Efficacy and safety of lisocabtagene maraleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: 31-month follow-up of the phase 2 TRANSCEND FL study.International journal of clinical oncology
Case reportPersistent multifocal pulmonary consolidations in a young adult: An unusual presentation of primary pulmonary follicular lymphoma.Respiratory medicine case reports
ReviewAdvances in CAR-T and CAR-NK Cell Therapy in Follicular Lymphoma: A Review.Transplantation and cellular therapy
[Clinical characteristics of acute thrombocytopenia in newly diagnosed follicular lymphoma patients receiving obinutuzumab chemotherapy].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital.Acta clinica Belgica
A tale of two triplets: tafasitamab or epcoritamab in combination with rituximab and lenalidomide in relapsed/refractory follicular lymphoma.Expert opinion on biological therapy
Meta-analysisRituximab Versus Watchful Waiting for Asymptomatic Advanced-Stage Low-Tumor-Burden Follicular Lymphoma: A Systematic Review and Meta-Analysis.Clinical lymphoma, myeloma & leukemia
In plain wordsRead moreRead the paper on PubMedFDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research
Safe and effective rechallenge of zanubrutinib in combination with obinutumumab in follicular lymphoma after severe drug-induced liver injury.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Case reportConcurrent follicular lymphoma and follicular dendritic cell sarcoma: composite neoplasm or transdifferentiation?Journal of hematopathology
Shared Genetic Basis of Autoimmune Diseases and Follicular Lymphoma by Mendelian Randomization and Multi-Omics.Genes
Case reportTransformation of Parotid Gland Follicular Lymphoma to Diffuse Large B-Cell Lymphoma with Gastric Relapse and Perforation: A Case Report.Annals of clinical and laboratory science
Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine-Rituximab Therapy for Follicular Lymphoma.Clinical case reports
Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era.Haematologica
Case reportA patient's experience with follicular lymphoma from diagnosis to cure: the life-changing impact of CAR T-cell therapy.Future oncology (London, England)
Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA.Clinical drug investigation
Plain language summary of the ZUMA-5 study of axicabtagene ciloleucel for people with relapsed or refractory slow-growing non-Hodgkin lymphoma.Future oncology (London, England)
Socioeconomic disparities in survival among follicular lymphoma patients.Scientific reports
Case reportUnusually long remission in two patients with follicular lymphoma receiving immunomodulating therapeutic cancer vaccines.Leukemia research reports
Occupational exposure to radiofrequency electromagnetic fields and risk of follicular lymphoma: Family case-control study.Cancer epidemiology
Commentary: Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1-3a follicular lymphoma.Frontiers in immunology
Follicular Dendritic Cell Staining Pattern as a Prognostic Marker for the Watch-and-Wait Policy in Patients with Gastrointestinal Follicular Lymphoma.Digestion
Case reportSimultaneous DOTATATE uptake in three non-neuroendocrine pathologies: Follicular lymphoma, Crohn's disease, and vertebral hemangioma.Radiology case reports
ReviewFollicular lymphoma and the microenvironment: potential targets and biomarkers.Expert review of clinical immunology
[The prognostic value of IGHV gene segment usage in advanced-stage follicular lymphoma with bone marrow infiltration].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
[Wiskott-Aldrich syndrome with follicular lymphoma: a case report].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Incidental diagnosis of primary appendiceal follicular lymphoma following appendectomy.Cancer treatment and research communications
Case reportCXCR4-targeted PET/CT with Al18F-NOTA-Pentixather shows superior sensitivity to 18F-FDG in thyroid follicular lymphoma.Hellenic journal of nuclear medicine
Case reportParaneoplastic pemphigus associated with follicular lymphoma and myasthenia gravis: Efficacy of a lenalidomide-rituximab-corticosteroid regimen.JAAD case reports
A framework to challenge the dogma of incurability in follicular lymphoma.Blood
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.British journal of haematology
Clinical features of primary intestinal follicular lymphoma: A single-center retrospective study.The Journal of international medical research
Trial resultCD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.The Lancet. Haematology
In plain wordsRead moreRead the paper on PubMedLTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.British journal of haematology
Trial resultEpcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial.The Lancet. Haematology
In plain wordsRead moreRead the paper on PubMedReviewCanadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.Current oncology (Toronto, Ont.)
Primary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience.PloS one
Case reportAcute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Meta-analysisreFLASH: a proof-of-concept meta-analytic framework to validate surrogate endpoints in the absence of randomized clinical trial data.Journal of clinical epidemiology
In plain wordsRead moreRead the paper on PubMedComparative Analysis of the Clinicopathological Features of Follicular Lymphoma With and Without EZH2 Y646 Mutation.Pathology international
Case reportRare Presentation of Sequential Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leukemia: A Case-Based Review.Journal of community hospital internal medicine perspectives
Casulo C, Dixon JG, Le-Rademacher J, et al; FLASH (Follicular Lymphoma Analysis of Surrogacy Hypothesis) Group. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood. 2022;139(11):1684-1693.Blood
Follicular Lymphoma Involving the Supraglottic Larynx in a Patient with Recurrent Cutaneous B-cell Lymphoproliferative Lesions: A Case Report.Internal medicine (Tokyo, Japan)
Trial resultGlofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study.British journal of haematology
In plain wordsRead moreRead the paper on PubMedMosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Case reportOral dysaesthesia associated with obinutuzumab - a case report.British dental journal
Follicular Lymphoma Arising in an Ileal Neobladder Presenting as a Large Pelvic Mass.IJU case reports
Personalizing Maintenance Rituximab in Follicular Lymphoma: A Machine Learning Framework for Risk-Benefit Optimization.Health data science
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.HemaSphere
MNDA-positive Follicular Lymphoma is a heterogeneous disease: a case series study of 19 patients.Virchows Archiv : an international journal of pathology
Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1-3a follicular lymphoma.Frontiers in immunology
Tumoral immune microenvironment profiling in B-cell non-Hodgkin lymphoma stratifies patients in different prognostic groups.Frontiers in immunology
Impact of Prior Bendamustine Exposure on Chimeric Antigen Receptor T-Cell Therapy Outcomes in Follicular Lymphoma.Transplantation and cellular therapy
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.HemaSphere
ReviewOncogenic Role of BCL6 Rearrangement: A Focus on Follicular and Marginal Zone Lymphomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Early Follicular Lymphoma Grading via PET-CT Fusion and Bayesian Deep Learning.Journal of imaging informatics in medicine
Case report[Synchronous Follicular Lymphoma and Lung Adenocarcinoma-A Case Report].Gan to kagaku ryoho. Cancer & chemotherapy
Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.Cancer discovery
Case report[Clinicopathological Characteristics of Follicular Lymphoma with a Predominantly Diffuse Growth Pattern].Zhongguo shi yan xue ye xue za zhi
Case report[Clinicopathological analysis of nodal follicular helper T-cell lymphomas, angioimmunoblastic-type with EBV-positive neoplastic cells].Zhonghua bing li xue za zhi = Chinese journal of pathology
Case report[Successful treatment of CD30-positive nodal follicular helper T-cell lymphoma, follicular type, with A-CHP and tucidinostat].[Rinsho ketsueki] The Japanese journal of clinical hematology
Trial resultExposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.Clinical pharmacokinetics
In plain wordsRead moreRead the paper on PubMedFixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.Journal of the advanced practitioner in oncology
ReviewMosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes.Human vaccines & immunotherapeutics
Unmasking a Composite Lymphoma: Follicular Lymphoma Emerging After Bispecific Antibody Treatment of Marginal Zone Lymphoma.EJHaem
ReviewFollicular Lymphoma: Novel Therapies and Strategies for Optimal Therapeutic Sequencing.Current oncology reports
Trial resultA distinct CAR-T cell phenotype mediates therapeutic response at limited doses.Nature communications
In plain wordsRead moreRead the paper on PubMedA Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen.Journal of clinical medicine
Cytomorphological Differentiation of Follicular Lymphoma Grades 1-2 and Non-Neoplastic Lymphoid Tissues Using ImageJ.Diagnostic cytopathology
Unexpected Detection of Acute Oxidative Hemolysis Revealing G6PD Deficiency in a Patient With Follicular Lymphoma.International journal of laboratory hematology
Integrating Multi-Omics Mendelian Randomization and Functional Validation to Identify Novel Apoptosis Regulators in Follicular Lymphoma.Technology in cancer research & treatment
CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.Blood
Ocular Follicular Lymphoma with Marginal Zone Differentiation: A Diagnostic Pitfall Mimicking MALT Lymphoma.Internal medicine (Tokyo, Japan)
Case reportManagement Strategies for Osseous Follicular Lymphoma of the Spine.Cureus
Trial resultDurable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL.Blood
In plain wordsRead moreRead the paper on PubMedCost-Effectiveness of Epcoritamab Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab for Relapsed/Refractory Follicular Lymphoma: A US Payer Perspective.Hematological oncology
Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.British journal of haematology
Case reportLong-term remission of severe psoriasis following CD19-directed chimeric antigen receptor T-cell therapy for follicular lymphoma.Clinical and experimental dermatology
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts.Blood cancer journal
Follicular Lymphoma Developing During IL-17A Inhibitor Therapy in a Patient With Psoriasis: Retreatment Without Lymphoma Progression.International journal of dermatology
Trial resultMRD negativity by PBMCs and ctDNA confirms deep and durable responses after epcoritamab monotherapy in R/R FL.Blood advances
In plain wordsRead moreRead the paper on PubMedMechanisms of resistance to macrophage checkpoint inhibitors in B-cell non-Hodgkin lymphoma.British journal of haematology
Trial resultComparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma.Oncoimmunology
In plain wordsRead moreRead the paper on PubMedRetroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.Leukemia
Meta-analysisEfficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis.Current research in translational medicine
In plain wordsRead moreRead the paper on PubMedObinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.Frontiers in immunology
Trial resultPhase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.International journal of clinical oncology
In plain wordsRead moreRead the paper on PubMedCase reportParaneoplastic Pemphigus Associated with Follicular Lymphoma, Sjögren's Syndrome, and Bronchiolitis Obliterans: A Case of Prolonged Survival.Case reports in dermatology
Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.JCO clinical cancer informatics
Systematic reviewClinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis.British journal of haematology
In plain wordsRead moreRead the paper on PubMedUtility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases.Journal of hematopathology
Case reportRare Leukemic Phase of Follicular Lymphoma With a High-Risk Follicular Lymphoma International Prognostic Index (FLIPI) Score Treated With Bendamustine-Rituximab.Cureus
ReviewCD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions.Medicina (Kaunas, Lithuania)
Durability Benchmarking of Contemporary Second-Line and Later Therapies for Relapsed or Refractory Follicular Lymphoma Using Reconstructed Individual Patient Data From Published Kaplan-Meier Curves.Cureus
Digital and Manual Assessment of Intrafollicular Ki-67, MYC, and p53 in Classic Follicular Lymphoma.Diagnostics (Basel, Switzerland)
Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. Cancers 2026, 18, 395.Cancers
Randomised trialRENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma.Blood advances
In plain wordsRead moreRead the paper on PubMedPrimary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology.Blood research
Randomised trialTen-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.The New England journal of medicine
In plain wordsRead moreRead the paper on PubMedAssociation of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis.Annals of hematology
Mosunetuzumab Successfully Treated Rituximab-Refractory Lymphoma-Associated Protein-Losing Enteropathy With Concomitant Immune Thrombocytopenia in Follicular Lymphoma: A Case Report.EJHaem
Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.HemaSphere
The RELEVANCE of long-term follow-up in follicular lymphoma.Blood
Beyond the Surface: Duodenal-Type Follicular Lymphoma Diagnosed Despite Normal-Appearing Duodenal Mucosa and Absence of Focal Duodenal FDG Uptake.Case reports in gastrointestinal medicine
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.Blood cancer journal
Observational studyOutcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study.European journal of cancer (Oxford, England : 1990)
ReviewOdronextamab: a bispecific antibody for follicular lymphoma.Expert opinion on investigational drugs
Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with Epcoritamab.International journal of molecular sciences
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.Global & regional health technology assessment
Case reportA "Double-Hit" Lymphoma With Plasmablastic Features and Aberrant Keratin Expression Likely Transforming From Follicular Lymphoma.International journal of surgical pathology
Beyond Chemoimmunotherapy: Emerging Cellular and Targeted Therapies in Transformed Follicular Lymphoma: A Scoping Review.Cancer control : journal of the Moffitt Cancer Center
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study.HemaSphere